Community | December 22, 2011 | 0 comments

FDA expands use of HIV drug Isentress to children and adolescents

Image
joeeddy
Isentress (raltegravir) was approved today by the U.S. Food and Drug Administration for use with other antiretroviral drugs for the treatment of HIV-1 infection for children and adolescents ages 2-18.
  1. groups:
    Community
  2. tags:
    Health HIV FDA worldwide hippies news 1 more
  3.     
    |

0 comments // FDA expands use of HIV drug Isentress to children and adolescents

more from Community:

top videos